Loading chat...
NY A03116
Bill
Status
1/23/2025
Primary Sponsor
Linda Rosenthal
Click for details
AI Summary
-
Requires practitioners to discuss risks of addiction, overdose, and dangerous drug interactions with patients before issuing an initial Schedule II controlled substance or opioid prescription for pain, and again before the third prescription in a course of treatment
-
Mandates discussion of why the prescription is necessary, available alternative treatments, and specific warnings that opioids are highly addictive even when taken as prescribed
-
For patients under 18 who are not emancipated minors, the required discussion must occur with the patient's parent or guardian
-
Requires physicians to counsel patients on overdose risks and inform them about opioid antagonists like naloxone when prescribing more than a one-week supply of opioid analgesics as the first such prescription of a calendar year
-
Directs the Department of Health to develop and provide guidelines for practitioners on conducting these required patient discussions
-
Takes effect 120 days after becoming law
Legislative Description
Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.
Last Action
referred to health
1/7/2026